Systemic Inflammation is Associated with Cardiometabolic Risk Factors and Clinical Outcomes.

Global inflammation scores encompassing an array of pro- and anti-inflammatory proteins and pathways may enhance risk assessment for cardiometabolic diseases. The AIS and PCA scores provide further opportunities to investigate the mechanisms of inflammation-related risk of disease.